Comment on ‘The efficacy and toxicity of gemcitabine, carboplatin and bevacizumab in metastatic breast cancer‘

Detalles Bibliográficos
Autores principales: Kitchen, D, O'Brien, M, Hughes, B, Gill, I, Rumbles, S, Ellis, P, Stebbing, J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3721388/
https://www.ncbi.nlm.nih.gov/pubmed/23756861
http://dx.doi.org/10.1038/bjc.2013.279
_version_ 1782278063540666368
author Kitchen, D
O'Brien, M
Hughes, B
Gill, I
Rumbles, S
Ellis, P
Stebbing, J
author_facet Kitchen, D
O'Brien, M
Hughes, B
Gill, I
Rumbles, S
Ellis, P
Stebbing, J
author_sort Kitchen, D
collection PubMed
description
format Online
Article
Text
id pubmed-3721388
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-37213882013-07-24 Comment on ‘The efficacy and toxicity of gemcitabine, carboplatin and bevacizumab in metastatic breast cancer‘ Kitchen, D O'Brien, M Hughes, B Gill, I Rumbles, S Ellis, P Stebbing, J Br J Cancer Letter to the Editor Nature Publishing Group 2013-07-23 2013-06-11 /pmc/articles/PMC3721388/ /pubmed/23756861 http://dx.doi.org/10.1038/bjc.2013.279 Text en Copyright © 2013 Cancer Research UK http://creativecommons.org/licenses/by-nc-sa/3.0/ This work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
spellingShingle Letter to the Editor
Kitchen, D
O'Brien, M
Hughes, B
Gill, I
Rumbles, S
Ellis, P
Stebbing, J
Comment on ‘The efficacy and toxicity of gemcitabine, carboplatin and bevacizumab in metastatic breast cancer‘
title Comment on ‘The efficacy and toxicity of gemcitabine, carboplatin and bevacizumab in metastatic breast cancer‘
title_full Comment on ‘The efficacy and toxicity of gemcitabine, carboplatin and bevacizumab in metastatic breast cancer‘
title_fullStr Comment on ‘The efficacy and toxicity of gemcitabine, carboplatin and bevacizumab in metastatic breast cancer‘
title_full_unstemmed Comment on ‘The efficacy and toxicity of gemcitabine, carboplatin and bevacizumab in metastatic breast cancer‘
title_short Comment on ‘The efficacy and toxicity of gemcitabine, carboplatin and bevacizumab in metastatic breast cancer‘
title_sort comment on ‘the efficacy and toxicity of gemcitabine, carboplatin and bevacizumab in metastatic breast cancer‘
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3721388/
https://www.ncbi.nlm.nih.gov/pubmed/23756861
http://dx.doi.org/10.1038/bjc.2013.279
work_keys_str_mv AT kitchend commentontheefficacyandtoxicityofgemcitabinecarboplatinandbevacizumabinmetastaticbreastcancer
AT obrienm commentontheefficacyandtoxicityofgemcitabinecarboplatinandbevacizumabinmetastaticbreastcancer
AT hughesb commentontheefficacyandtoxicityofgemcitabinecarboplatinandbevacizumabinmetastaticbreastcancer
AT gilli commentontheefficacyandtoxicityofgemcitabinecarboplatinandbevacizumabinmetastaticbreastcancer
AT rumbless commentontheefficacyandtoxicityofgemcitabinecarboplatinandbevacizumabinmetastaticbreastcancer
AT ellisp commentontheefficacyandtoxicityofgemcitabinecarboplatinandbevacizumabinmetastaticbreastcancer
AT stebbingj commentontheefficacyandtoxicityofgemcitabinecarboplatinandbevacizumabinmetastaticbreastcancer

Ejemplares similares